Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway
Authors
Keywords
-
Journal
ONCOGENE
Volume 41, Issue 20, Pages 2885-2896
Publisher
Springer Science and Business Media LLC
Online
2022-04-15
DOI
10.1038/s41388-022-02313-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting FGFR inhibition in cholangiocarcinoma
- (2021) Lipika Goyal et al. CANCER TREATMENT REVIEWS
- HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc
- (2021) Zhipeng Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways
- (2021) Tianli Chen et al. MOLECULAR THERAPY
- FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis
- (2021) Tianli Chen et al. ONCOGENE
- Pemigatinib: First Approval
- (2020) Sheridan M. Hoy DRUGS
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
- (2020) Phillip C. C. Liu et al. PLoS One
- Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
- (2020) Ian M. Silverman et al. Cancer Discovery
- Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1
- (2019) Zengli Liu et al. EBioMedicine
- Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway
- (2019) Rongqi Sun et al. EBioMedicine
- Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle
- (2019) Bo Qiu et al. EBioMedicine
- HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium
- (2018) Yun-Fei Xu et al. ONCOGENE
- SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
- (2018) Xiaodong Yuan et al. BRITISH JOURNAL OF CANCER
- FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1
- (2017) Tingting Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
- (2017) Wen Min Lau et al. MOLECULAR CANCER THERAPEUTICS
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Mechanism of FGF receptor dimerization and activation
- (2016) Sarvenaz Sarabipour et al. Nature Communications
- Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts
- (2015) Alexis Poncy et al. DEVELOPMENTAL BIOLOGY
- FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder
- (2015) Eric W. Fan et al. JOURNAL OF UROLOGY
- Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma
- (2014) Yun-Fei Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sox9 and programming of liver and pancreatic progenitors
- (2013) Yoshiya Kawaguchi JOURNAL OF CLINICAL INVESTIGATION
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9
- (2009) Aline Antoniou et al. GASTROENTEROLOGY
- Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating -Catenin Signaling
- (2008) R. Pai et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started